Skip to main content

Brattleboro Back Into Opioid Negotiating Class

Brattleboro Back Into Opioid Negotiating Class

Brattleboro Back Into Opioid Negotiating Class

Introduction

On Tuesday, the Brattleboro Selectboard decided to move back into an opioid national negotiating class,  after opting out a week ago.

The class, which includes every town, city, and county in the country, is formed to seek comprehensive settlements with drug companies, distributors, and pharmacy chains involved in the lawsuit. In the meantime, the town will also proceed with an individual lawsuit.

The class includes more than 34,000 potential class members, managed by 49 counties and cities serving as class representatives, negotiating with up to 13 corporate defendants.

The members of the class have the right to vote on any proposed settlement with a majority of 75 percent approval. Also, being a part of the class will not prevent a town or city from bringing its own lawsuit, and a municipality can’t collect twice from the same defendant.

Companies manufacturing opioids convinced the medical community that these medications were not addictive and were purely beneficial. This belief raised the number of prescriptions and sales unwarrantedly, resulting in a mass misuse of these drugs, to the extent that this was identified by the U.S. Food and Drug Administration (FDA) as a public issue and named it an opioid crisis.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!